(-0.07%) 5 304.50 points
(-0.02%) 40 134 points
(-0.11%) 18 484 points
(0.77%) $81.98
(-1.75%) $1.688
(0.28%) $2 218.80
(-0.64%) $24.59
(-0.01%) $909.60
(0.46%) $0.928
(0.69%) $10.84
(0.28%) $0.793
(-0.15%) $92.31
Live Chart Being Loaded With Signals
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery...
Stats | |
---|---|
Today's Volume | 199.00 |
Average Volume | 955.00 |
Market Cap | 11.58B |
EPS | $1.030 ( 2023-06-30 ) |
Last Dividend | $1.174 ( 2023-03-23 ) |
Next Dividend | $0 ( N/A ) |
P/E | 38.42 |
ATR14 | $0.230 (0.18%) |
Carl Zeiss Meditec AG Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Carl Zeiss Meditec AG Financials
Annual | 2023 |
Revenue: | $2.09B |
Gross Profit: | $1.21B (57.71 %) |
EPS: | $3.25 |
Q4 | 2023 |
Revenue: | $579.70M |
Gross Profit: | $340.27M (58.70 %) |
EPS: | $0.960 |
Q3 | 2023 |
Revenue: | $535.12M |
Gross Profit: | $315.97M (59.05 %) |
EPS: | $1.030 |
Q2 | 2023 |
Revenue: | $504.22M |
Gross Profit: | $292.17M (57.95 %) |
EPS: | $0.690 |
Financial Reports:
No articles found.
Carl Zeiss Meditec AG Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$1.174 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.527 | 2013-03-01 |
Last Dividend | $1.174 | 2023-03-23 |
Next Dividend | $0 | N/A |
Payout Date | 2023-04-11 | |
Next Payout Date | N/A | |
# dividends | 11 | -- |
Total Paid Out | $7.38 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.22 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.87 | |
Div. Directional Score | 8.70 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SBSNY | Ex Dividend Junior | 2023-05-02 | Annually | 0 | 0.00% | |
HCBC | Ex Dividend Knight | 2023-08-10 | Quarterly | 0 | 0.00% | |
ASXFY | Ex Dividend Knight | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
VWAGY | Ex Dividend Junior | 2023-05-11 | Annually | 0 | 0.00% | |
MYBF | Ex Dividend Knight | 2023-10-04 | Quarterly | 0 | 0.00% | |
DBOEY | Ex Dividend Knight | 2023-05-17 | Annually | 0 | 0.00% | |
SPKKY | Ex Dividend Knight | 2023-09-14 | Annually | 0 | 0.00% | |
HVRRY | Ex Dividend Junior | 2023-05-04 | Annually | 0 | 0.00% | |
BKUT | Ex Dividend Junior | 2023-06-29 | Semi-Annually | 0 | 0.00% | |
OSAGY | No Dividend Player | 2023-06-16 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.132 | 1.500 | 7.36 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0912 | 1.200 | 6.96 | 8.35 | [0 - 0.3] |
returnOnEquityTTM | 0.136 | 1.500 | 9.60 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.356 | -1.000 | 6.44 | -6.44 | [0 - 1] |
currentRatioTTM | 3.40 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 2.25 | 0.800 | 1.470 | 1.176 | [0.8 - 2.5] |
cashRatioTTM | 0.0189 | 1.500 | -1.006 | -1.509 | [0.2 - 2] |
debtRatioTTM | 0.0513 | -1.500 | 9.14 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 24.02 | 1.000 | 2.22 | 2.22 | [3 - 30] |
operatingCashFlowPerShareTTM | 2.62 | 2.00 | 9.13 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.345 | 2.00 | 9.33 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0721 | -1.500 | 9.71 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.573 | 1.000 | 3.78 | 3.78 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.196 | 1.000 | 8.08 | 8.08 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.501 | 1.000 | 2.77 | 2.77 | [0.2 - 2] |
assetTurnoverTTM | 0.690 | 0.800 | 8.73 | 6.98 | [0.5 - 2] |
Total Score | 10.53 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 38.49 | 1.000 | 6.21 | 0 | [1 - 100] |
returnOnEquityTTM | 0.136 | 2.50 | 9.74 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.345 | 2.00 | 9.55 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.692 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 2.62 | 2.00 | 9.13 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.356 | 1.500 | 6.44 | -6.44 | [0 - 1] |
pegRatioTTM | 1.692 | 1.500 | 2.05 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.112 | 1.000 | 9.71 | 0 | [0.1 - 0.5] |
Total Score | 6.87 |
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries. It serves practicing ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, dental and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators